Review of Treatment Options for the Management of Advanced Stage Hodgkin Lymphoma

Hodgkin lymphoma (HL) is a lymphoid-type hematologic disease that is derived from B cells. The incidence of this lymphoid malignancy is around 2–3/100,000/year in the western world. Long-term remission rates are linked to a risk-adapted approach, which allows remission rates higher than 80%. The fir...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancers 2021-07, Vol.13 (15), p.3745
Hauptverfasser:	Vellemans, Hélène, André, Marc P. E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Bleomycin Cardiovascular diseases Chemotherapy Cyclophosphamide Dacarbazine Disease control Doxorubicin Etoposide Fertility Hematological diseases Hematology Hodgkin's lymphoma Immune checkpoint Lymphocytes Lymphocytes B Lymphoma Malignancy Medical prognosis Neutropenia Patients Positron emission tomography Prednisone Procarbazine Radiation therapy Remission Remission (Medicine) Review Toxicity Vinblastine Vincristine Women Young adults
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!